Masimo (NASDAQ:MASI) announced fiscal fourth-quarter results that exceeded expectations. The health technology company reported earnings of $1.25 per share, outperforming the Wall Street estimate of $0.88. Its quarterly revenue also exceeded projections, totaling $548.9 million versus the anticipated $544.81 million.

For the next quarter, Masimo predicts earnings per share to range from $0.67 to $0.74, compared to the analyst consensus of $0.73. The company expects revenue for fiscal Q1 2024 to be between $476 million and $501 million, below the forecasted $514.4 million.

Looking at the full fiscal year of 2024, Masimo provides an earnings guidance of $3.44 to $3.60 per share, above the expected $3.32 by analysts. The company anticipates revenue to be between $2.045 billion and $2.165 billion, compared to the Street estimate of $2.1 billion.